title: RapidTEG observation suggests activation of factor VII may overcome argatroban-induced coagulopathy.
authors.forename: Michael L
authors.initials: ML
authors.lastname: Schmitz
authors.forename: Edgar D
authors.initials: ED
authors.lastname: St Amour
authors.forename: H Lynn
authors.initials: HL
authors.lastname: Harness
authors.forename: Wesley A
authors.initials: WA
authors.lastname: McKamie
authors.forename: Charles E
authors.initials: CE
authors.lastname: Johnson
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives; D001778:Blood Coagulation Disorders / Q000139:chemically induced* / Q000201:enzymology* / Q000517:prevention & control; D002648:Child; D005167:Factor VII / Q000378:metabolism*; D005260:Female; D006801:Humans; D010875:Pipecolic Acids / Q000009:adverse effects*; D013449:Sulfonamides; D013916:Thrombelastography / Q000379:methods; D013997:Time Factors
chemical_list: D010875:Pipecolic Acids; D013449:Sulfonamides; D005167:Factor VII; D001120:Arginine; C031942:argatroban